---
id: 1511934782233407488
author:yudapearl
published_date:{{PUBLISHED_DATE }}
conversation_id: Conversation-1511885963072401413
in_reply_to: 1511931441097031686
retweet: None
quoted_tweet: None
---

@soboleffspaces EBM fears comes from the  fact that adjustment  methods in observational studies require knowledge of the DAG structure. In contrast, the adjustment recommended by FDA requires only that the predictors  be non-descendants of the treatment, nothing else.
I wish FDA spoke English.

### Metadata

Author: [[@yudapearl]]
Conversation: [[Conversation-1511885963072401413]]
In reply to: [[1511931441097031686]]
Retweet of: [[None]]
Quoted tweet: [[None]]
